You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 綠葉製藥早盤一度飆升70%,引入高瓴資本戰略投資
uSMART盈立智投 02-01 09:34

uSMART盈立智投2月1日消息,週一港股早盤,綠葉製藥高開高走,截至9:33分,一度飆升70%。

綠葉製藥此前公告稱,擬引入高瓴資本作爲戰略投資者持股達15.6%,認購價爲每股股份4.28港元,較其最新收盤價(3.89港元)溢價約10.03%。

綠葉製藥公佈,於2021年1月29日,公司引入Hillhouse NEV作爲戰略投資者,將持有公司合共5.52億股股份,相當於擴大後股本約15.6%。

公司向Hillhouse NEV配售2.92億股新股,佔擴大後股本約8.26%,配售價4.28元,較上週五收市價3.89元溢價10.03%,涉資12.515億元。此外,公司控股股東Lu Ye Investment向Hillhouse NEV出售2.6億股,佔現有股本約8%,作價同爲4.28元。

配售新股所得款項淨額約爲12.51億元,將用於集團的一般營運資金。

Hillhouse NEV爲一間根據英屬處女羣島法律成立的公司。高瓴資本管理有限公司擔任Hillhouse NEV的獨家投資經理。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account